Skip to Content
Logo
Menu
  • About Our Firm
  • Practice Areas
  • Our People
  • Learning Library
  • Corporate Transparency Act
  • Contact
  • Make A Payment

Safety Incentive Programs and Post-Incident Drug Testing: OSHA Adopts a More Permissive Stance

Safety Incentive Programs and Post-Incident Drug Testing: OSHA Adopts a More Permissive Stance

October 31, 2018

On October 11, 2018, OSHA published a Standard Interpretation Memorandum to clarify that it “does not prohibit workplace safety incentive programs and postincident drug [and alcohol] testing policies.” This memorandum was necessary because of confusion created by OSHA’s publication of a final rule in May 2016. The May 2016 rule established an employee’s right to report work-related injuries and illnesses. The rule also prohibited employers from discriminating against employees for reporting work-related injuries or illnesses. But, the rule created unintended consequences.

The Problem that OSHA Created for Employers in 2016

The May 2016 rule also included language that, “A procedure is not reasonable if it would deter or discourage a reasonable employee from accurately reporting a workplace injury or illness[.]” 29 CFR ยง1904.35(b). Employers were left to guess whether their safety incentive programs or their post-accident drug testing programs were “reasonable.” In prefatory comments to the rule it was suggested that drug testing after an accident was not always reasonable because it may “intimidate workers.” Remarks also suggested that certain employer incentive programs can actively discourage employees from reporting accidents.

OSHA’s Fix in 2018

Concluding that a fix was necessary, OSHA published its Standard Interpretation Memorandum in mid-October, 2018.

Safety Incentive Programs

The 2018 Memorandum acknowledges that safety incentive programs are effective tools for promoting workplace safety, and encourages employers to consider implementing programs that:

  1. Reward workers for reporting near-misses or unsafe conditions.
  2. Reward workers with a prize or bonus at the end of an injury-free month, if the program does not discourage employees from reporting workplace injuries or illnesses.

The Memorandum cautions that an employer’s anti-retaliation statements may not be enough to encourage employees to report injuries and illnesses if an employee loses a significant incentive when reporting an accident. The Memorandum provides examples for employers of policies that counteract any deterrents to reporting injuries, such as:

  1. Implementing a training program to reinforce reporting rights and responsibilities and emphasize the employer’s non-retaliation policy.
  2. Developing a mechanism for accurately evaluating employee willingness to report work-place injuries and illnesses.

Post-incident Drug and Alcohol Testing

OSHA provides five examples of permissible drug testing that prevent an employer from running afoul of its regulations in its memorandum:

  • Random drug testing.
  • Drug testing unrelated to the reporting of a work-related injury or illness.
  • Drug testing under a state workers’ compensation law.
  • Drug testing under other federal law, such as a U.S. Department of Transportation rule.
  • Drug testing to evaluate the root cause of a workplace incident that harmed or could have harmed employees. If the employer chooses to use drug testing to investigate the incident, the employer should test all employees whose conduct could have contributed to the incident, not just employees who reported injuries.

It is the fifth example that will prompt most questions. If you have any questions about whether your firm’s safety incentive program or drug testing program follows OSHA regulations, please contact us.

Related Attorneys

Clingen Callow & McLean, LLC
Lisle Office
2300 Cabot Drive, Suite 500
Lisle, Illinois, 60532
Phone 630.871.2600
Geneva Office
21 North 4th Street
Geneva, Illinois, 60134
Phone 630.938.4769
Fax 630.871.9869
General Inquires [email protected]
  • facebook
  • linkedin

Contact Us

©2025 Clingen Callow & McLean, LLC. All rights reserved.

Law Firm Web Design by NMC

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}